lipopolysaccharides (InvivoGen)
InvivoGen is a verified supplier 
InvivoGen manufactures this product 
93
Structured Review
InvivoGen
lipopolysaccharides
Lipopolysaccharides, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lps-eb+vaccigrade/LPS-EB+VacciGrade/pmc13639547-56-0-17
Average 93 stars, based on 28 article reviews
Lipopolysaccharides, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lps-eb+vaccigrade/LPS-EB+VacciGrade/pmc13639547-56-0-17
Average 93 stars, based on 28 article reviews
lipopolysaccharides - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Flow Cytometry:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Immunopeptidomics:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Knockdown:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Cytometry:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Synthesized:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Mouse Assay:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Aerosol:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Saline:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Incubation:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Concentration Assay:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Isolation:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Clinical Proteomics:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Expressing:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Positive Control:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Control:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Staining:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Red Blood Cell Lysis:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( Lysis:Article Title: Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation Article Snippet: ation determined by flow cytometry. To assess MHC-I-mediated antigen presentation, day 6 HLA-A*0201-type WT or galectin-9 knockdown moDCs were seeded at 1 × 10 6 cells/ml and treated with 1 μg/mL LPS ( |
